U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436988) titled 'Affordable Made-in-India Microspheres for Liver Cancer Therapy' on Jan. 19.
Brief Summary: Primary liver tumors, with hepatocellular carcinoma (HCC) accounting for 80%, represent 6% of global cancer incidence and 9% of global cancer-associated mortality.HCC remains the leading causes of cancer-related deaths worldwide, due to late diagnosis. Although local-stage liver tumors are curable with tumor resection or livertransplantation, 65-70% of diagnosed cases are not suitable for resection due to large or multifocal lesions. For these patients, local therapies such as transcatheterarterial chemoembolization (TACE) or selective interna...